|
Dr. Gill has more than 15 years of experience in international clinical research. He has spent 9 years in various leadership roles at Rhone-Poulenc Rorer (now Aventis) in the US and in Europe. During his tenure at RPR, he played a key role in the submission of a number of successful regulatory filings and also held positions in Process Improvement and Corporate Marketing. In his current position, Dr. Gill plays a leadership role in PharmaNet’s dedicated Oncology, Neuroscience, and Infectious Disease divisions. | 